Global Prostate Cancer Drugs Market Size, Share, Trends and Forecast 2021-2027

Description

The global Prostate Cancer Drugs market size is projected to reach US$ 9481.8 million by 2026, from US$ 6505.5 million in 2019, at a CAGR of 6.5% during 2021-2026.
Global Prostate Cancer Drugs Scope and Segment
Prostate Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
Prostate Cancer Drugs Breakdown Data by Type
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Prostate Cancer Drugs Breakdown Data by Application
Clinics
Hospitals
Other
Regional and Country-level Analysis
The Prostate Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prostate Cancer Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Prostate Cancer Drugs Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Drugs Market Size Growth Rate by Type
1.4.2 Hormonal Therapy
1.4.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Drugs Market Size Growth Rate by Application
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Prostate Cancer Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Prostate Cancer Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Prostate Cancer Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Prostate Cancer Drugs Regions by Sales
2.4.1 Global Top Prostate Cancer Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Prostate Cancer Drugs Regions by Sales (2022-2027)
2.5 Global Top Prostate Cancer Drugs Regions by Revenue
2.5.1 Global Top Prostate Cancer Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Prostate Cancer Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prostate Cancer Drugs Sales by Manufacturers
3.1.1 Global Top Prostate Cancer Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Prostate Cancer Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Prostate Cancer Drugs Sales in 2020
3.2 Global Prostate Cancer Drugs Revenue by Manufacturers
3.2.1 Global Top Prostate Cancer Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Prostate Cancer Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Drugs Revenue in 2020
3.3 Global Prostate Cancer Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prostate Cancer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Prostate Cancer Drugs Sales by Type
4.1.1 Global Prostate Cancer Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Prostate Cancer Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Prostate Cancer Drugs Sales Market Share by Type (2016-2027)
4.2 Global Prostate Cancer Drugs Revenue by Type
4.2.1 Global Prostate Cancer Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Prostate Cancer Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Prostate Cancer Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Prostate Cancer Drugs Price by Type
4.3.1 Global Prostate Cancer Drugs Price by Type (2016-2021)
4.3.2 Global Prostate Cancer Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Prostate Cancer Drugs Sales by Application
5.1.1 Global Prostate Cancer Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Prostate Cancer Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Prostate Cancer Drugs Sales Market Share by Application (2016-2027)
5.2 Global Prostate Cancer Drugs Revenue by Application
5.2.1 Global Prostate Cancer Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Prostate Cancer Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Prostate Cancer Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Prostate Cancer Drugs Price by Application
5.3.1 Global Prostate Cancer Drugs Price by Application (2016-2021)
5.3.2 Global Prostate Cancer Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Drugs Market Size by Type
6.1.1 North America Prostate Cancer Drugs Sales by Type (2016-2027)
6.1.2 North America Prostate Cancer Drugs Revenue by Type (2016-2027)
6.2 North America Prostate Cancer Drugs Market Size by Application
6.2.1 North America Prostate Cancer Drugs Sales by Application (2016-2027)
6.2.2 North America Prostate Cancer Drugs Revenue by Application (2016-2027)
6.3 North America Prostate Cancer Drugs Market Size by Country
6.3.1 North America Prostate Cancer Drugs Sales by Country (2016-2027)
6.3.2 North America Prostate Cancer Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prostate Cancer Drugs Market Size by Type
7.1.1 Europe Prostate Cancer Drugs Sales by Type (2017-2027)
7.1.2 Europe Prostate Cancer Drugs Revenue by Type (2017-2027)
7.2 Europe Prostate Cancer Drugs Market Size by Application
7.2.1 Europe Prostate Cancer Drugs Sales by Application (2017-2027)
7.2.2 Europe Prostate Cancer Drugs Revenue by Application (2017-2027)
7.3 Europe Prostate Cancer Drugs Market Size by Country
7.3.1 Europe Prostate Cancer Drugs Sales by Country (2017-2027)
7.3.2 Europe Prostate Cancer Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Drugs Market Size by Type
8.1.1 Asia Pacific Prostate Cancer Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Prostate Cancer Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Prostate Cancer Drugs Market Size by Application
8.2.1 Asia Pacific Prostate Cancer Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Prostate Cancer Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Prostate Cancer Drugs Market Size by Region
8.3.1 Asia Pacific Prostate Cancer Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Prostate Cancer Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Prostate Cancer Drugs Market Size by Type
9.1.1 Latin America Prostate Cancer Drugs Sales by Type (2019-2027)
9.1.2 Latin America Prostate Cancer Drugs Revenue by Type (2019-2027)
9.2 Latin America Prostate Cancer Drugs Market Size by Application
9.2.1 Latin America Prostate Cancer Drugs Sales by Application (2019-2027)
9.2.2 Latin America Prostate Cancer Drugs Revenue by Application (2019-2027)
9.3 Latin America Prostate Cancer Drugs Market Size by Country
9.3.1 Latin America Prostate Cancer Drugs Sales by Country (2019-2027)
9.3.2 Latin America Prostate Cancer Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Prostate Cancer Drugs Market Size by Type
6.1.1 Middle East and Africa Prostate Cancer Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Prostate Cancer Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Prostate Cancer Drugs Market Size by Application
6.2.1 Middle East and Africa Prostate Cancer Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Prostate Cancer Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Prostate Cancer Drugs Market Size by Country
6.3.1 Middle East and Africa Prostate Cancer Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Prostate Cancer Drugs Product Description
11.1.5 AbbVie Related Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Overview
11.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Astellas Pharma Prostate Cancer Drugs Product Description
11.2.5 Astellas Pharma Related Developments
11.3 Astra Zeneca
11.3.1 Astra Zeneca Corporation Information
11.3.2 Astra Zeneca Overview
11.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Astra Zeneca Prostate Cancer Drugs Product Description
11.3.5 Astra Zeneca Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Johnson & Johnson Prostate Cancer Drugs Product Description
11.4.5 Johnson & Johnson Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Sanofi Prostate Cancer Drugs Product Description
11.5.5 Sanofi Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Description
11.6.5 GlaxoSmithKline Related Developments
11.7 Merck Group
11.7.1 Merck Group Corporation Information
11.7.2 Merck Group Overview
11.7.3 Merck Group Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Merck Group Prostate Cancer Drugs Product Description
11.7.5 Merck Group Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Novartis Prostate Cancer Drugs Product Description
11.8.5 Novartis Related Developments
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Overview
11.9.3 Amgen Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Amgen Prostate Cancer Drugs Product Description
11.9.5 Amgen Related Developments
11.10 Bayer HealthCare
11.10.1 Bayer HealthCare Corporation Information
11.10.2 Bayer HealthCare Overview
11.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Bayer HealthCare Prostate Cancer Drugs Product Description
11.10.5 Bayer HealthCare Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Prostate Cancer Drugs Product Description
11.1.5 AbbVie Related Developments
11.12 Janssen Pharmaceuticals
11.12.1 Janssen Pharmaceuticals Corporation Information
11.12.2 Janssen Pharmaceuticals Overview
11.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Janssen Pharmaceuticals Product Description
11.12.5 Janssen Pharmaceuticals Related Developments
11.13 Endo Pharmaceuticals
11.13.1 Endo Pharmaceuticals Corporation Information
11.13.2 Endo Pharmaceuticals Overview
11.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Endo Pharmaceuticals Product Description
11.13.5 Endo Pharmaceuticals Related Developments
11.14 BMS
11.14.1 BMS Corporation Information
11.14.2 BMS Overview
11.14.3 BMS Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 BMS Product Description
11.14.5 BMS Related Developments
11.15 Takeda Pharmaceuticals
11.15.1 Takeda Pharmaceuticals Corporation Information
11.15.2 Takeda Pharmaceuticals Overview
11.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Takeda Pharmaceuticals Product Description
11.15.5 Takeda Pharmaceuticals Related Developments
11.16 Northwest Biotherapeutics
11.16.1 Northwest Biotherapeutics Corporation Information
11.16.2 Northwest Biotherapeutics Overview
11.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Northwest Biotherapeutics Product Description
11.16.5 Northwest Biotherapeutics Related Developments
11.17 Teva Pharmaceutical
11.17.1 Teva Pharmaceutical Corporation Information
11.17.2 Teva Pharmaceutical Overview
11.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Teva Pharmaceutical Product Description
11.17.5 Teva Pharmaceutical Related Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Corporation Information
11.18.2 Boehringer Ingelheim Overview
11.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 Boehringer Ingelheim Product Description
11.18.5 Boehringer Ingelheim Related Developments
11.19 Foresee Pharmaceuticals
11.19.1 Foresee Pharmaceuticals Corporation Information
11.19.2 Foresee Pharmaceuticals Overview
11.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.19.4 Foresee Pharmaceuticals Product Description
11.19.5 Foresee Pharmaceuticals Related Developments
11.20 Tokai Pharmaceuticals
11.20.1 Tokai Pharmaceuticals Corporation Information
11.20.2 Tokai Pharmaceuticals Overview
11.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.20.4 Tokai Pharmaceuticals Product Description
11.20.5 Tokai Pharmaceuticals Related Developments
11.21 Spectrum Pharmaceuticals
11.21.1 Spectrum Pharmaceuticals Corporation Information
11.21.2 Spectrum Pharmaceuticals Overview
11.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.21.4 Spectrum Pharmaceuticals Product Description
11.21.5 Spectrum Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Prostate Cancer Drugs Value Chain Analysis
12.2 Prostate Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Drugs Production Mode & Process
12.4 Prostate Cancer Drugs Sales and Marketing
12.4.1 Prostate Cancer Drugs Sales Channels
12.4.2 Prostate Cancer Drugs Distributors
12.5 Prostate Cancer Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prostate Cancer Drugs Industry Trends
13.2 Prostate Cancer Drugs Market Drivers
13.3 Prostate Cancer Drugs Market Challenges
13.4 Prostate Cancer Drugs Market Restraints

14 Key Findings in The Global Prostate Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample